Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone. - Wikidata - wikimedia - TriplyDB

Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone.

Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone.

http://www.wikidata.org/entity/Q33202267

about

The amazing osteocyte Nuclear receptors in bone physiology and diseases Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia MEPE is a novel regulator of growth plate cartilage mineralization SP7 inhibits osteoblast differentiation at a late stage in mice Single nucleotide polymorphisms in bone turnover-related genes in Koreans: ethnic differences in linkage disequilibrium and haplotype.Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator.Activation of bone remodeling after fatigue: differential response to linear microcracks and diffuse damage Surface immobilization of MEPE peptide onto HA/β-TCP ceramic particles enhances bone regeneration and remodeling.Collagen osteoid-like model allows kinetic gene expression studies of non-collagenous proteins in relation with mineral development to understand bone biomineralization MEPE expression in osteocytes during orthodontic tooth movement Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets.The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled.Emerging and potential therapies for osteoporosis.FGF23 production by osteocytes.Fibroblast growth factor 23 and bone mineralisation.Emerging pharmacologic therapies for osteoporosis.Genetic analysis of vertebral trabecular bone density and cross-sectional area in older men.Regulation of CYP27B1 mRNA Expression in Primary Human Osteoblasts Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition.Dissection of genetic factors modulating fetal growth in cattle indicates a substantial role of the non-SMC condensin I complex, subunit G (NCAPG) gene.Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice.Osteocytes: central conductors of bone biology in normal and pathological conditions.The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis.An in situ hybridization study of perlecan, DMP1, and MEPE in developing condylar cartilage of the fetal mouse mandible and limb bud cartilage.MEPE's diverse effects on mineralization.Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE.Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.

P2860

Q24635849-9D8B235D-9953-4D46-8BF3-A20F1DEC2B27 Q26853017-B0E5AE3D-A78A-4E24-B0BC-6EE959489A3F Q27002346-34E7A9FE-5675-43AA-8058-CAFD873089A6 Q27026805-15BEF4B4-7B7F-494B-A26C-1FBFCD9AC97D Q28511009-B7DEC568-B4A8-430E-8F9A-455F335DCC7B Q28593877-206DE488-2348-4582-B455-A8E796A51680 Q28731578-A0FCB883-BE9A-4934-85F3-9BC68CE6EAC3 Q33307072-EE4FDCA8-5E15-4AF6-8121-DF5EF0A2721F Q33643995-FE21D9C5-B980-4332-A824-8E06BA0E6BAD Q34126530-FDD5B973-275A-4885-91CF-E1274023E438 Q34249760-A679E8BD-AF5A-424A-A36F-D22AAD94458C Q34608502-DD9347D7-6DC7-4403-AB18-D3D3D75D2354 Q35792574-35C78F7F-7A56-4695-8E1D-92BA8F061C84 Q35920063-1BFC44DF-5900-4D2B-AA39-D973425A323C Q35975734-FB73D80E-A949-4D99-BFFA-822A44807DFC Q36074718-5C863450-9D55-48DC-B9D9-FD53687641B1 Q36099415-AFCA37BF-4FC2-440F-8C8F-A7C5BB3214E3 Q36639867-E891FF2D-3E4D-4EDF-99FD-D4DE9E4BE4C5 Q36756061-ACBFC7D2-243F-4939-BC6D-9CA44CF6BDB9 Q36944034-E847756A-99A3-48D0-A083-7F4483852FAF Q36951167-4B1ACD2F-8859-4C5F-9503-4EC93C61EACF Q37063172-8DBF1C9C-73B8-4741-93D7-B0FA2C6288A8 Q37285119-A7682B96-137D-4FC4-936E-A97481B9A40E Q37425049-571F49FA-C7DE-47A4-B6DC-DAFB1BCC2E67 Q37440758-62EE71C6-A477-4545-B5E7-8EB3A742F4AA Q37621495-DF327A71-D5C1-43C7-B535-EBD1C2913452 Q37958204-C3790816-1095-45E7-B664-7DB391B47820 Q38836379-544BE2B7-F2ED-48BB-886B-99DDA1F72743 Q39214999-970220DD-A435-4C2F-B7D8-29C50D445E36 Q41087451-DD75A675-4ED6-4066-B2E8-C933CAD4F217 Q41763685-05590042-3AC2-4534-8A8C-B3250339CAC1 Q41788435-DC818E1D-B13D-459D-A759-B4EE94C0CE84 Q54360634-0AE8ED4D-7375-40A3-8170-E7D890AC5772

P2860

Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone.

http://www.wikidata.org/entity/Q33202267

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Matrix extracellular phosphogl ...... d in osteocytes in human bone.

@ast

Matrix extracellular phosphogl ...... d in osteocytes in human bone.

@en

type

label

Matrix extracellular phosphogl ...... d in osteocytes in human bone.

@ast

Matrix extracellular phosphogl ...... d in osteocytes in human bone.

@en

prefLabel

Matrix extracellular phosphogl ...... d in osteocytes in human bone.

@ast

Matrix extracellular phosphogl ...... d in osteocytes in human bone.

@en

P1433

Q33202267-3D80CD65-9CB8-4C1E-A1EF-F30EBF47EEF3

P1476

Q33202267-2A59A7EF-4FD6-4BB4-8E5B-90E0B774E670

P2093

Q33202267-1AC48820-58C4-49C5-BE3D-A96A1E0A966C

Q33202267-2158652A-437B-4509-93F4-25534F038FAB

Q33202267-28FC0637-1149-4E13-8BDB-D044FCB37F52

Q33202267-2961ADA5-9CAF-409B-B143-FBF3E2579266

Q33202267-64D157BD-2B43-457E-A6C5-3C3E91BAF072

Q33202267-6617E0CC-180E-47E4-97BF-D6531985303B

Q33202267-8A5DEB39-AFAD-4024-A3F5-A2EFD0E0845F

Q33202267-8E9A9FF4-3B43-41D7-8932-9579AAA43D4B

Q33202267-A5E15DA2-03B6-4751-A3EB-4D8BA8CC8280

Q33202267-AABEC9D6-7BA1-4E0A-8AAC-FFF95B0B8659

P2888

Q33202267-393301E2-8C40-4A89-9C84-20779461ADB6

P304

Q33202267-A729CFB8-1891-46ED-AA30-25FC1CB6A3D8

P31

Q33202267-AD3222B6-973E-407C-8C84-88D3B40A5034

P356

Q33202267-65D8E536-0892-4FD8-831A-C2A276A5A10A

P433

Q33202267-2FA52BAB-25D0-4040-AAFD-E55FAD024A2B

P478

Q33202267-8B0B569F-2B82-46C0-A941-0D1996220A99

P577

Q33202267-432D05D7-C61E-47D4-A462-640ADEE16058

P698

Q33202267-5D6AEAC5-5D0C-4CEB-A26E-FCE455E4FE78

P921

Q33202267-21DCC561-D862-4B9C-8DF7-94FDFFF7FCD2

P356

S00774-003-0468-9

P1433

Journal of Bone and Mineral Metabolism

P1476

Matrix extracellular phosphogl ...... d in osteocytes in human bone.

@en

P2093

Akihide Nampei

http://www.w3.org/2001/XMLSchema#string

Hideaki Miyashita

http://www.w3.org/2001/XMLSchema#string

Hideki Tsuboi

http://www.w3.org/2001/XMLSchema#string

Hideki Yoshikawa

http://www.w3.org/2001/XMLSchema#string

Isamu Tsuji

http://www.w3.org/2001/XMLSchema#string

Jun Hashimoto

http://www.w3.org/2001/XMLSchema#string

Kenji Hayashida

http://www.w3.org/2001/XMLSchema#string

Kenrin Shi

http://www.w3.org/2001/XMLSchema#string

Masayuki Matsumoto

http://www.w3.org/2001/XMLSchema#string

Naomichi Matsukawa

http://www.w3.org/2001/XMLSchema#string

P2888

s00774-003-0468-9

P304

176-184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00774-003-0468-9

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15108058

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix